Daniel Mueller

1.7k total citations · 1 hit paper
45 papers, 888 citations indexed

About

Daniel Mueller is a scholar working on Pharmacology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Daniel Mueller has authored 45 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 9 papers in Psychiatry and Mental health and 6 papers in Molecular Biology. Recurrent topics in Daniel Mueller's work include Pharmacogenetics and Drug Metabolism (6 papers), Treatment of Major Depression (6 papers) and Diet and metabolism studies (5 papers). Daniel Mueller is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Treatment of Major Depression (6 papers) and Diet and metabolism studies (5 papers). Daniel Mueller collaborates with scholars based in United States, Canada and Germany. Daniel Mueller's co-authors include James L. Kennedy, Vincenzo De Luca, Andrea Gaedigk, Teri E. Klein, Andrea de Bartolomeis, Kelly E. Caudle, J. Steven Leeder, Jeffrey R. Bishop, Katrin Sangkuhl and Jacob T. Brown and has published in prestigious journals such as Contemporary Sociology A Journal of Reviews, Scientific Reports and Biological Psychiatry.

In The Last Decade

Daniel Mueller

40 papers receiving 843 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

2023 181 citations Katrin Sangkuhl, Daniel Mueller et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Mueller United States	14	263	256	142	137	107	45	888
Taku Nakagami Japan	19	177 0.7×	454 1.8×	156 1.1×	135 1.0×	77 0.7×	50	941
Eva J. Brandl Germany	20	199 0.8×	368 1.4×	93 0.7×	110 0.8×	248 2.3×	56	1.1k
Takuro Sugai Japan	19	96 0.4×	386 1.5×	82 0.6×	75 0.5×	132 1.2×	63	862
Vesna Medved Croatia	16	101 0.4×	286 1.1×	89 0.6×	45 0.3×	90 0.8×	26	605
Matthew Macaluso United States	14	203 0.8×	209 0.8×	104 0.7×	372 2.7×	91 0.9×	64	902
Judith C. Kando United States	15	133 0.5×	741 2.9×	199 1.4×	264 1.9×	68 0.6×	40	1.2k
Johanna Sasse Germany	12	156 0.6×	300 1.2×	61 0.4×	138 1.0×	85 0.8×	15	679
Katja Maino Germany	7	84 0.3×	328 1.3×	44 0.3×	170 1.2×	75 0.7×	9	1.1k
Helen Fung Kum Chiu Hong Kong	20	115 0.4×	240 0.9×	46 0.3×	63 0.5×	167 1.6×	29	1.1k
Serafino G. Mancuso Australia	19	86 0.3×	324 1.3×	80 0.6×	87 0.6×	121 1.1×	45	1.1k

Countries citing papers authored by Daniel Mueller

Since Specialization

Citations

This map shows the geographic impact of Daniel Mueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Mueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Mueller more than expected).

Fields of papers citing papers by Daniel Mueller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Mueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Mueller. The network helps show where Daniel Mueller may publish in the future.

Co-authorship network of co-authors of Daniel Mueller

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Mueller. A scholar is included among the top collaborators of Daniel Mueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Mueller. Daniel Mueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Husain, Muhammad Ishrat, Daniel M. Blumberger, Stefan Kloiber, et al.. (2025). Challenges Related to the Implementation of Measurement-Based Care for the Treatment of Major Depressive Disorder: A Feasibility Study. Pharmacopsychiatry. 58(4). 170–177. 2 indexed citations

Meyyappan, Arthi Chinna, et al.. (2025). The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression – A Phase 2, Double-Blind, Placebo-Controlled Study: Clinical Results: Innocuité et efficacité du traitement de l'écosystème microbien (met–2) dans la dépression majeure – une étude de phase 2 à double insu contrölée par placebo : résultats cliniques. The Canadian Journal of Psychiatry. 70(11). 816–823.

Zhang, Aihua, Arun K. Tiwari, Clement C. Zai, et al.. (2025). Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review. Pharmacogenomics. 26(7-9). 295–309.

Patel, Jai N., Sarah Morris, Raúl Torres, et al.. (2024). Pharmacogenomic insights in psychiatric care: uncovering novel actionability, allele-specific CYP2D6 copy number variation, and phenoconversion in 15,000 patients. Molecular Psychiatry. 29(11). 3495–3502. 2 indexed citations

Singh, Raghunath, Sandra Pereira, Thomas D. Prévot, et al.. (2024). Human-fecal microbiota transplantation in relation to gut microbiome signatures in animal models for schizophrenia: A scoping review. Asian Journal of Psychiatry. 102. 104285–104285. 3 indexed citations

Marshe, Victoria, Farhana Islam, Vanessa F. Gonçalves, et al.. (2024). Polygenic score analyses on antidepressant response in late-life depression, results from the IRL-GRey study. The Pharmacogenomics Journal. 24(6). 38–38. 5 indexed citations

Mueller, Daniel, et al.. (2023). To intervene or not to intervene: A case of symptomatic neurocysticercosis complicated by ventriculitis. IDCases. 31. e01702–e01702.

Pouget, Jennie G., Emiko Koyama, Clement C. Zai, et al.. (2022). Exploring the association of interleukin polymorphisms with aggression and internalizing behaviors in children and adolescents. Brain and Behavior. 12(11). e2753–e2753. 4 indexed citations

Allen, Timothy A., Kate L. Harkness, Raymond W. Lam, et al.. (2021). Interactions between neuroticism and stressful life events predict response to pharmacotherapy for major depression: A CAN‐BIND 1 report. Personality and Mental Health. 15(4). 273–282. 1 indexed citations

10.

Topitzes, James, et al.. (2019). Implementing Trauma Screening, Brief Intervention, and Referral to Treatment (T‐SBIRT) within Employment Services: A Feasibility Trial. American Journal of Community Psychology. 64(3-4). 298–309. 13 indexed citations

11.

Brown, Jacob T., Jeffrey R. Bishop, Katrin Sangkuhl, et al.. (2019). Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy. Clinical Pharmacology & Therapeutics. 106(1). 94–102. 136 indexed citations

12.

MacKenzie, Nicole E., Chantel Kowalchuk, Sri Mahavir Agarwal, et al.. (2018). Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia. Frontiers in Psychiatry. 9. 622–622. 135 indexed citations

13.

Mueller, Daniel, Victoria Marshe, Małgorzata Maciukiewicz, et al.. (2018). F120. Genome-Wide Analyses of Venlafaxine Response in Late-Life Depression. Biological Psychiatry. 83(9). S284–S284. 1 indexed citations

14.

Marshe, Victoria, Małgorzata Maciukiewicz, Soham Rej, et al.. (2017). 232. Genome-Wide Association Study of Venlafaxine Treatment Remission in Late-Life Depression. Biological Psychiatry. 81(10). S95–S96. 1 indexed citations

15.

Zai, Clement C., Arun K. Tiwari, Nicole King, et al.. (2009). Association study of the gamma-aminobutyric acid type a receptor γ2 subunit gene with schizophrenia. Schizophrenia Research. 114(1-3). 33–38. 11 indexed citations

16.

Pike, W. T., M. H. Hecht, M. S. Anderson, et al.. (2000). Atomic Force Microscope for Imaging and Spectroscopy. 3 indexed citations

17.

Krauß, H., Daniel Mueller, Thomas Held, et al.. (2000). Zur Reliabilität und Validität der deutschen Version der Prämorbiden Anpassungsskala (PAS). Der Nervenarzt. 71(3). 188–194. 10 indexed citations

18.

Mueller, Daniel, et al.. (1992). Mengukur Sikap Sosial : Pegangan untuk peneliti dan praktisi. 7 indexed citations

19.

Mueller, Daniel. (1985). Career Orientation Placement and Evaluation Survey. Measurement and Evaluation in Counseling and Development. 18(3). 132–134. 6 indexed citations

20.

Mueller, Daniel. (1974). A Test of the Validity of Two Scales on Rokeach's Value Survey. The Journal of Social Psychology. 94(2). 289–290. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact